# PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification

> **NCT05049837** · — · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 7200 (estimated)

## Conditions studied

- Lung Cancer
- Cancer of Thorax

## Interventions

- **OTHER:** Group Specific Aim 1
- **OTHER:** Group Specific Aim 2
- **OTHER:** Group Specific Aim 3
- **OTHER:** Group Specific Aim 4
- **OTHER:** Group Specific Aim 5
- **OTHER:** Group Specific Aim 6

## Key facts

- **NCT ID:** NCT05049837
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2007-04-25
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 7200 (ESTIMATED)
- **Last updated:** 2025-08-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05049837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05049837, "PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05049837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*